These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12868305)

  • 21. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.
    Kohli R; Shevitz A; Gorbach S; Wanke C
    HIV Med; 2007 Oct; 8(7):420-6. PubMed ID: 17760733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients.
    Florescu D; Kotler DP
    Antivir Ther; 2007; 12(2):149-62. PubMed ID: 17503657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
    Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
    Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.
    Casula M; van der Valk M; Wit FW; Nievaard MA; Reiss P
    HIV Med; 2007 Jan; 8(1):32-7. PubMed ID: 17305930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipodystrophies: what treatment?].
    Vigouroux C
    Journ Annu Diabetol Hotel Dieu; 2003; ():159-77. PubMed ID: 12868308
    [No Abstract]   [Full Text] [Related]  

  • 28. Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy.
    Merchante N; García-García JA; Vergara S; Mira JA; Macías J; Pineda JA
    HIV Med; 2004 Nov; 5(6):448-9. PubMed ID: 15544698
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.
    Haugaard SB; Andersen O; Hales CN; Halsall I; Rosenfalck AM; Iversen J; Madsbad S
    Eur J Clin Invest; 2006 Jun; 36(6):436-45. PubMed ID: 16684128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo.
    Lagathu C; Kim M; Maachi M; Vigouroux C; Cervera P; Capeau J; Caron M; Bastard JP
    Biochimie; 2005 Jan; 87(1):65-71. PubMed ID: 15733739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial comment: a case definition for HIV lipodystrophy--a work in progress.
    Wanke C
    AIDS Read; 2003 Oct; 13(10):492-3. PubMed ID: 14596226
    [No Abstract]   [Full Text] [Related]  

  • 34. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic therapy for HIV-associated lipodystrophy.
    Benavides S; Nahata MC
    Ann Pharmacother; 2004 Mar; 38(3):448-57. PubMed ID: 14755064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Criteria for AIDS-prices 2003. Why does HAART therapy in HIV patients cause fat catabolism?].
    Urologe A; 2003 Sep; 42(9):1254. PubMed ID: 14619845
    [No Abstract]   [Full Text] [Related]  

  • 37. Adipose tissue as an endocrine organ: impact on insulin resistance.
    Jazet IM; Pijl H; Meinders AE
    Neth J Med; 2003 Jun; 61(6):194-212. PubMed ID: 12948164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of lipo-atrophic diabetes].
    Romero E; Romero Bobillo E
    Rev Iber Endocrinol; 1970; 17(101):391-7. PubMed ID: 5501996
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Management of lipoatrophic diabetes.
    Upton GV; Corbin A; Mabry CC; Hollingsworth DR
    N Engl J Med; 1975 Mar; 292(11):592. PubMed ID: 1110678
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.
    Bergersen BM; Sandvik L; Ellingsen I; Bruun JN
    HIV Med; 2005 Jul; 6(4):260-7. PubMed ID: 16011531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.